33.76
price up icon6.26%   1.99
after-market Handel nachbörslich: 33.40 -0.36 -1.07%
loading

Finanzdaten der Guardant Health Inc-Aktie (GH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
8.67%
168.49
155.05 143.03 137.15 128.71
Operating Expenses
23.94%
268.17
352.56 256.57 256.77 262.77
Interest Income/Expense
0.00%
0.645
0.645 0.644 0.645 0.644
Benefits Costs and Expenses
17.38%
283.07
342.64 228.64 209.43 262.01
Costs And Expenses
23.94%
268.17
352.56 256.57 256.77 262.77
Operating Income/Loss
49.53%
-99.68
-197.51 -113.54 -119.62 -134.06
Income/Loss From Continuing Operations Before Tax
38.92%
-114.58
-187.58 -85.61 -72.28 -133.29
Income Tax Expense/Benefit
174.86%
0.405
-0.541 0.49 0.496 0.24
Income/Loss From Continuing Operations After Tax
38.52%
-114.98
-187.04 -86.10 -72.77 -133.53
Net Income/Loss
38.52%
-114.98
-187.04 -86.10 -72.77 -133.53
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,440%
121.71
2.197 117.74 108.81 102.66
Diluted Average Shares
5,440%
121.71
2.197 117.74 108.81 102.66
Basic Earnings Per Share
41.98%
-0.94
-1.62 -0.73 -0.67 -1.30
Diluted Earnings Per Share
41.98%
-0.94
-1.62 -0.73 -0.67 -1.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research LH
$229.15
price up icon 0.42%
$136.01
price up icon 3.88%
diagnostics_research WAT
$371.76
price up icon 0.95%
$167.60
price up icon 4.36%
diagnostics_research MTD
$1,238.28
price up icon 1.43%
$415.53
price up icon 1.63%
Kapitalisierung:     |  Volumen (24h):